Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes.
Florian G ScurtJan MenneSabine BrandtAnja BernhardtPeter R MertensHermann HallerChristos ChatzikyrkouPublished in: Diabetes/metabolism research and reviews (2023)
sTNF-R1 and sTNF-R2 failed to predict the occurrence of microalbuminuria in normoalbuminuric patients with type 2 diabetes. Likewise, the utility of endostatin in predicting new onset proteinuria is limited.
Keyphrases